Latest Insider Transactions at Alkermes Plc. (ALKS)
This section provides a real-time view of insider transactions for Alkermes Plc. (ALKS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Alkermes plc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Alkermes plc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 20
2023
|
Blair Curtis Jackson EVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,316
-2.07%
|
$120,848
$28.07 P/Share
|
|
Feb 20
2023
|
Blair Curtis Jackson EVP, Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,086
+8.59%
|
-
|
|
Feb 20
2023
|
Blair Curtis Jackson EVP, Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,589
+4.45%
|
-
|
|
Feb 20
2023
|
Michael J Landine SVP, Corp Dev., Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
7,604
-1.54%
|
$212,912
$28.07 P/Share
|
|
Feb 20
2023
|
Michael J Landine SVP, Corp Dev., Alkermes, Inc. |
BUY
Grant, award, or other acquisition
|
Direct |
11,770
+4.51%
|
-
|
|
Feb 20
2023
|
Michael J Landine SVP, Corp Dev., Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
5,354
+2.18%
|
-
|
|
Feb 20
2023
|
Christian Todd Nichols SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,878
-8.56%
|
$220,584
$28.07 P/Share
|
|
Feb 20
2023
|
Christian Todd Nichols SVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,969
+31.06%
|
-
|
|
Feb 20
2023
|
Christian Todd Nichols SVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,824
+11.6%
|
-
|
|
Feb 20
2023
|
Iain Michael Brown SVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,316
-2.9%
|
$120,848
$28.07 P/Share
|
|
Feb 20
2023
|
Iain Michael Brown SVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,086
+11.52%
|
-
|
|
Feb 20
2023
|
Iain Michael Brown SVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,589
+6.26%
|
-
|
|
Feb 20
2023
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,306
-11.74%
|
$288,568
$28.07 P/Share
|
|
Feb 20
2023
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,195
+29.69%
|
-
|
|
Feb 20
2023
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,095
+22.81%
|
-
|
|
Feb 18
2023
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,945
-1.87%
|
$54,460
$28.07 P/Share
|
|
Feb 18
2023
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
6,230
+5.65%
|
-
|
|
Feb 18
2023
|
Blair Curtis Jackson EVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,683
-2.78%
|
$75,124
$28.07 P/Share
|
|
Feb 18
2023
|
Blair Curtis Jackson EVP, Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,722
+8.28%
|
-
|
|
Feb 18
2023
|
Michael J Landine SVP, Corp Dev., Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
2,065
-0.87%
|
$57,820
$28.07 P/Share
|
|
Feb 18
2023
|
Michael J Landine SVP, Corp Dev., Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
4,361
+1.81%
|
-
|
|
Feb 18
2023
|
Christian Todd Nichols SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,961
-7.19%
|
$54,908
$28.07 P/Share
|
|
Feb 18
2023
|
Christian Todd Nichols SVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,230
+18.6%
|
-
|
|
Feb 18
2023
|
Iain Michael Brown SVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,965
-2.97%
|
$55,020
$28.07 P/Share
|
|
Feb 18
2023
|
Iain Michael Brown SVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,230
+8.61%
|
-
|
|
Feb 18
2023
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,656
-9.94%
|
$74,368
$28.07 P/Share
|
|
Feb 18
2023
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,722
+24.61%
|
-
|
|
Feb 10
2023
|
David Angelo Daglio Jr. Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,445
+22.66%
|
-
|
|
Feb 10
2023
|
Brian P Mckeon Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,445
+22.66%
|
-
|
|
Dec 08
2022
|
Cato T Laurencin Director |
SELL
Payment of exercise price or tax liability
|
Direct |
763
-7.03%
|
$19,075
$25.48 P/Share
|
|
Dec 08
2022
|
Cato T Laurencin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,242
+42.1%
|
-
|
|
Nov 14
2022
|
David Angelo Daglio Jr. Director |
BUY
Open market or private purchase
|
Indirect |
35,000
+30.43%
|
$805,000
$23.31 P/Share
|
|
Jun 21
2022
|
Christian Todd Nichols SVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
7,474
-26.22%
|
$209,272
$28.26 P/Share
|
|
Jun 14
2022
|
Emily Peterson Alva Director |
SELL
Payment of exercise price or tax liability
|
Direct |
905
-6.85%
|
$24,435
$27.19 P/Share
|
|
Jun 14
2022
|
Emily Peterson Alva Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,585
+36.46%
|
-
|
|
Jun 14
2022
|
David W Anstice Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,585
+8.2%
|
-
|
|
Jun 14
2022
|
Shane Cooke Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,945
-4.02%
|
$106,515
$27.19 P/Share
|
|
Jun 14
2022
|
Shane Cooke Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,585
+7.18%
|
-
|
|
Jun 14
2022
|
David Angelo Daglio Jr. Director |
SELL
Payment of exercise price or tax liability
|
Direct |
795
-6.9%
|
$21,465
$27.19 P/Share
|
|
Jun 14
2022
|
David Angelo Daglio Jr. Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,585
+39.7%
|
-
|
|
Jun 14
2022
|
Wendy L Dixon Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,585
+12.49%
|
-
|
|
Jun 14
2022
|
Richard Gaynor Director |
SELL
Payment of exercise price or tax liability
|
Direct |
695
-4.21%
|
$18,765
$27.19 P/Share
|
|
Jun 14
2022
|
Richard Gaynor Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,585
+31.46%
|
-
|
|
Jun 14
2022
|
Brian P Mckeon Director |
SELL
Payment of exercise price or tax liability
|
Direct |
795
-6.9%
|
$21,465
$27.19 P/Share
|
|
Jun 14
2022
|
Brian P Mckeon Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,585
+39.7%
|
-
|
|
Jun 14
2022
|
Nancy Lynn Md Snyderman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
695
-4.1%
|
$18,765
$27.19 P/Share
|
|
Jun 14
2022
|
Nancy Lynn Md Snyderman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,585
+30.91%
|
-
|
|
Jun 14
2022
|
Frank Anders Wilson Director |
SELL
Payment of exercise price or tax liability
|
Direct |
695
-4.21%
|
$18,765
$27.19 P/Share
|
|
Jun 14
2022
|
Frank Anders Wilson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,585
+31.46%
|
-
|
|
Jun 14
2022
|
Nancy Wysenski Director |
SELL
Payment of exercise price or tax liability
|
Direct |
695
-4.21%
|
$18,765
$27.19 P/Share
|